Table 1

Anesthetic-induced modulation of [3H]muscimol binding in wild-type and mutant GABAA receptors

Subunit CombinationEC50Emax
μM % control
Pentobarbital
 α1β2 23.40  ± 2.6252.20  ± 5.69
 α1(G223F)β2 14.70  ± 2.141-a 56.20  ± 6.55
 α1β2(G219F)9.60  ± 1.771-a 21.20  ± 4.991-a 1-b
 α1(G223F)β2(G219F)5.60  ± 1.211-a 1-b 41.80  ± 4.97
 ρ1 NR1-g NR1-g
 ρ1(F261G)306.30  ± 49.701-a 1-e 1-f −29.80  ± 6.511-a 1-e 1-f
 ρ1(NASM-RNSL)NR1-g NR1-g
Alphaxalone
 α1β2 0.44  ± 0.0760.80  ± 4.13
 α1(G223F)β2 0.17  ± 0.031-a 71.80  ± 9.47
 α1β2(G219F)0.12  ± 0.031-a −11.80  ± 1.491-a 1-b 1-d
 α1(G223F)β2(G219F)0.08  ± 0.031-a 35.50  ± 3.931-a 1-b
 ρ1 NR1-g NR1-g
 ρ1(F261G)0.27  ± 0.11−28.00  ± 3.701-a 1-b 1-d 1-e
 ρ1(NASM-RNSL)0.70  ± 0.191-e −15.0  ± 3.161-a 1-b 1-d
Etomidate
 α1β2 1.83  ± 0.13300.30  ± 39.40
 α1(G223F)β2 0.48  ± 0.041-a 1-c 117.70  ± 6.171-a
 α1β2(G219F)2.92  ± 0.5619.70  ± 5.701-a 1-b
 α1(G223F)β2(G219F)0.94  ± 0.201-a 1-c 59.30  ± 0.881-a
 ρ1 NR1-g NR1-g
 ρ1(F261G)0.40  ± 0.151-a 1-c 19.70  ± 1.451-a 1-b 1-e 1-f
 ρ1(NASM-RNSL)NR1-g NR1-g
Propofol
 α1β2 6.20  ± 0.85166.30  ± 16.33
 α1(G223F)β2 4.09  ± 0.991-d 77.30  ± 1.201-a
 α1β2(G219F)1.61  ± 0.471-a 1-d 35.30  ± 5.041-a 1-b
 α1(G223F)β2(G219F)8.06  ± 1.0017.30  ± 4.481-a 1-b
 ρ1 NR1-g NR1-g
 ρ1(F261G)6.70  ± 0.4921.30  ± 7.311-a 1-b
 ρ1(NASM-RNSL)NR1-g NR1-g
  • From the curve fit of concentration-response data, values (n = 3–4 experiments performed in triplicate, mean ± S.E.) indicate the EC50 andE max for modulation by each i.v. anesthetic. Control values were evaluated in the absence of anesthetic.

  • 1-a P < .05 compared with α1β2.

  • 1-b P < .05 compared with α1(G223F)β2.

  • 1-c P < .05 compared with α1β2(G219F).

  • 1-d P < .05 compared with α1(G223F)β2(G219F).

  • 1-e P < .05 compared with ρ1.

  • 1-f P < .05 compared with ρ1(NASM-RNSL).

  • 1-g NR, tested with no statistically significant response,P > .05.